Federated Hermes’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-13,134
Closed -$2.79M 2154
2014
Q4
$2.79M Sell
13,134
-15,425
-54% -$3.07M 0.01% 825
2014
Q3
$5.09M Buy
28,559
+17,829
+166% +$2.96M 0.02% 635
2014
Q2
$1.82M Sell
10,730
-471,557
-98% -$73.4M 0.01% 993
2014
Q1
$59.9M Buy
482,287
+93,083
+24% +$11.3M 0.2% 106
2013
Q4
$43.2M Buy
389,204
+343,158
+745% +$32.8M 0.15% 136
2013
Q3
$4.17M Sell
46,046
-371,619
-89% -$33.4M 0.02% 649
2013
Q2
$35.2M Buy
+417,665
New +$43.3M 0.14% 144

Other funds holding AGN

Federated Hermes's AGN Position: Q1 2015 in Review

Federated Hermes sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 13,134 shares — an estimated $2.79M sold.

Federated Hermes first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $59.9M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Federated Hermes reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Federated Hermes sold 13,134 Allergan Inc shares in Q1 2015, an estimated $2.79M.
  • Federated Hermes first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Federated Hermes's Allergan Inc position peaked at $59.9M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Federated Hermes's 13F filing for Q1 2015, filed 8 May 2015.